$1.065
+0.134 (+12.62%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Acurx Pharmaceuticals Inc (ACXP) Moving Averages Convergence Divergence (MACD) indicator is -0.07, suggesting ACXP is Sell.
Acurx Pharmaceuticals Inc (ACXP) 20-Day simple moving average is 1.10, while Acurx Pharmaceuticals Inc (ACXP) share price is $—, making it Sell.
Acurx Pharmaceuticals Inc (ACXP) 60-Day simple moving average is 1.29, while Acurx Pharmaceuticals Inc (ACXP) share price is $—, making it Sell.
Technical Analysis for ACXP
AI Technical ACXPAs of 2026-11-07, the technical board for Acurx Pharmaceuticals Inc (ACXP) reads sell: 3 indicators are flashing buy, 7 are indicating sell, and 3 are neutral. Price at $1.07 sits below the 20-day, 60-day and 200-day moving averages and above the 5-day and 10-day.
Momentum readings: RSI stands at 41.672, MACD stands at -0.0712 (Sell), Stochastic %K stands at 19.633 (Buy), Stochastic %D stands at 12.187 and CCI stands at -77.733.
ACXP trades below the 60-day SMA (1.29) and below the 200-day SMA (1.94). Immediate resistance sits at Classic R1 1.14, then R2 1.23. Support sits at Classic S1 0.95, then S2 0.85.
Acurx Pharmaceuticals Inc (ACXP) Support & Resistance Level
Acurx Pharmaceuticals Inc (ACXP) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 41.672 |
| STOCHk_14_3_3 | 19.633 |
| STOCHd_14_3_3 | 12.187 |
| CCI_20 | -77.733 |
| AO_5_34 | -0.146 |
| MOM_10 | -0.075 |
| MACD_12_26_9 | -0.071 |
Acurx Pharmaceuticals Inc (ACXP) Relative Strength Index (RSI_14) is 41.672, creating a Neutral signal.
Acurx Pharmaceuticals Inc (ACXP) Stochastic %K is 19.633, creating a Buy signal.
Acurx Pharmaceuticals Inc (ACXP) Stochastic %D is 12.187, creating a Buy signal.
Acurx Pharmaceuticals Inc (ACXP) CCI_20 is -77.733, creating a Neutral signal.
Acurx Pharmaceuticals Inc (ACXP) Awesome Oscillator (AO) is -0.146, creating a Sell signal.
Acurx Pharmaceuticals Inc (ACXP) Momentum (MOM) is -0.075, creating a Sell signal.
Acurx Pharmaceuticals Inc (ACXP) Moving Average Convergence Divergence (MACD) is -0.071, creating a Sell signal.
Acurx Pharmaceuticals Inc (ACXP) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.025 | Buy |
| MA_10 | 1.045 | Buy |
| MA_20 | 1.103 | Sell |
| MA_60 | 1.289 | Sell |
| MA_200 | 1.935 | Sell |
| MA_250 | 2.259 | Sell |
Acurx Pharmaceuticals Inc (ACXP) 5-Day simple moving average is 1.025, while Acurx Pharmaceuticals Inc (ACXP) share price is $, making it a Buy.
Acurx Pharmaceuticals Inc (ACXP) 10-Day simple moving average is 1.045, while Acurx Pharmaceuticals Inc (ACXP) share price is $, making it a Buy.
Acurx Pharmaceuticals Inc (ACXP) 20-Day simple moving average is 1.103, while Acurx Pharmaceuticals Inc (ACXP) share price is $, making it a Sell.
Acurx Pharmaceuticals Inc (ACXP) 60-Day simple moving average is 1.289, while Acurx Pharmaceuticals Inc (ACXP) share price is $, making it a Sell.
Acurx Pharmaceuticals Inc (ACXP) 200-Day simple moving average is 1.935, while Acurx Pharmaceuticals Inc (ACXP) share price is $, making it a Sell.
Acurx Pharmaceuticals Inc (ACXP) 250-Day simple moving average is 2.259, while Acurx Pharmaceuticals Inc (ACXP) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.